Overview

Influence of Pioglitazone for Renal Transplant Function in Diabetics

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether pioglitazone is able to prevent the progression of diabetic nephropathy in kidney transplant recipients with diabetes mellitus.
Phase:
Phase 3
Details
Lead Sponsor:
Technische Universität Dresden
Treatments:
Pioglitazone